Fulcrum Therapeutics Inc (FULC)

3.315 +0.06 (+1.69%) USD  |  NASDAQ  |  Nov 05, 16:00
3.315 0.00 (0.00%) After-Hours: 16:16
More

Fulcrum Therapeutics Cash from Financing (Quarterly): 0.377M for June 30, 2024

Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2018. Upgrade now.
Date Value
June 30, 2024 0.377M
March 31, 2024 1.651M
December 31, 2023 0.287M
September 30, 2023 0.00
June 30, 2023 0.142M
March 31, 2023 117.69M
December 31, 2022 0.218M
September 30, 2022 80.95M
June 30, 2022 2.811M
March 31, 2022 0.348M
December 31, 2021 0.891M
September 30, 2021 137.90M
June 30, 2021 0.209M
Date Value
March 31, 2021 47.50M
December 31, 2020 6.255M
September 30, 2020 -0.083M
June 30, 2020 64.69M
March 31, 2020 0.274M
December 31, 2019 -0.281M
September 30, 2019 65.20M
June 30, 2019 -0.529M
March 31, 2019 -0.047M
December 31, 2018 -0.09M
September 30, 2018 79.82M
June 30, 2018 12.65M
March 31, 2018 12.64M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

-0.281M
Minimum
Dec 2019
137.90M
Maximum
Sep 2021
24.31M
Average
0.377M
Median
Jun 2024

Cash from Financing (Quarterly) Benchmarks

Bioventus Inc -7.845M
Arcturus Therapeutics Holdings Inc 2.403M
Entrada Therapeutics Inc 101.37M
Johnson & Johnson -9.882B
Insmed Inc 397.20M

Cash from Financing (Quarterly) Related Metrics

Cash from Operations (Quarterly) 58.90M
Cash from Investing (Quarterly) -12.51M
Free Cash Flow -12.62M
Free Cash Flow Per Share (Quarterly) 0.9263
Free Cash Flow to Equity (Quarterly) 58.90M
Free Cash Flow Yield -6.11%